| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/07/1995 | US5387431 Saccharide-based matrix |
| 02/07/1995 | US5387421 Plug releaseable upon application of pressure from inner chamber |
| 02/07/1995 | US5387420 Storage stability |
| 02/07/1995 | US5387419 System for controlled release of antiarrhythmic agents |
| 02/07/1995 | US5387415 Solution of skeleton former is mixed with extract; dropping dispersion into very cold liquid to form pellets; drying |
| 02/07/1995 | US5387411 Free of in situ entrapped active ingredients |
| 02/07/1995 | CA2030911C Pharmaceutical preparations |
| 02/07/1995 | CA2000168C Oral compositions |
| 02/07/1995 | CA1334281C Emulsion for parenteral administration |
| 02/03/1995 | CA2129274A1 Pharmaceutical composition |
| 02/03/1995 | CA2129099A1 Pharmaceutical compositions having good dissolution properties |
| 02/02/1995 | WO1995003357A1 Biodegradable particles |
| 02/02/1995 | WO1995003356A1 Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| 02/02/1995 | WO1995003272A1 Novel organic products containing reactive thiol functions, one method for preparing same, and biomaterials containing said products |
| 02/02/1995 | WO1995003083A1 Drug delivery |
| 02/02/1995 | WO1995003063A1 Oral pharmaceutical compositions comprising reduced glutathion |
| 02/02/1995 | WO1995003061A1 Preparation for improving the blood supply containing hard magnetic particles |
| 02/02/1995 | WO1995003052A1 Controlled release tacrine drug delivery systems and methods for preparing same |
| 02/02/1995 | WO1995003050A2 Improved nicotine lozenge and therapeutic method for smoking cessation |
| 02/02/1995 | WO1995003043A1 Sustained release oral compositions containing melatonin |
| 02/02/1995 | WO1995003036A1 Anti-angiogenic compositions and methods of use |
| 02/02/1995 | WO1995003035A1 Polymerized liposomes with enhanced stability for oral delivery |
| 02/02/1995 | WO1995003034A1 Stabilization of aerosolized proteins |
| 02/02/1995 | WO1995003033A1 Osmotic devices having vapor-permeable coatings |
| 02/02/1995 | WO1995003009A1 Method of treatment of macular degeneration |
| 02/02/1995 | WO1994028780A3 Methods of preparing gas and gaseous precursor-filled microspheres |
| 02/02/1995 | WO1994027587A3 Sustained antiepileptic therapy |
| 02/02/1995 | WO1994024984A3 Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto |
| 02/02/1995 | DE4400770C1 Plaster containing an active substance for delivery of oestradiol with at least one penetration enhancer, method of producing it and its use |
| 02/02/1995 | DE4325465A1 Oral pharmaceutical preparation for the therapy of pain |
| 02/02/1995 | DE4325100A1 Highly fluorinated alkanes and medicinal applications |
| 02/02/1995 | CA2472404A1 Combination of stent and anti-angiogenic factor |
| 02/02/1995 | CA2468375A1 Anti-angiogenic compositions, uses and methods |
| 02/02/1995 | CA2167920A1 Nonoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| 02/02/1995 | CA2167538A1 Stabilization of aerosolized proteins |
| 02/02/1995 | CA2161538A1 Controlled release tacrine drug delivery systems and methods for preparing same |
| 02/01/1995 | EP0636693A2 Maltose-trehalose converting enzyme, and preparation and uses thereof |
| 02/01/1995 | EP0636632A2 Non-reducing oligosaccharides and their production and use |
| 02/01/1995 | EP0636618A1 Spontaneously dispersible concentrates and microemulsions with vitamin E compounds for the preparation of medicaments with anti-tumour activity |
| 02/01/1995 | EP0636378A1 Absorbable composite materials for use in the treatment of periodontal disease |
| 02/01/1995 | EP0636374A2 A spermicidal anti-viral lubricant composition |
| 02/01/1995 | EP0636370A1 Sustained release compositions containing morphine |
| 02/01/1995 | EP0636366A2 Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| 02/01/1995 | EP0636365A1 Freeze-dried pharmaceutical dosage form and process for preparation thereof |
| 02/01/1995 | EP0636364A1 Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof |
| 02/01/1995 | EP0636363A2 Drug delivery system |
| 02/01/1995 | EP0636362A2 The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
| 02/01/1995 | EP0636315A1 Slow-releasing compositions |
| 02/01/1995 | EP0636033A1 Process for producing active agent complexes |
| 02/01/1995 | EP0636028A1 Self-assembling polynucleotide delivery system |
| 02/01/1995 | EP0636023A1 Aminoguanidine spray drying process |
| 02/01/1995 | EP0636020A1 A pharmaceutical carrier system containing defined lipids |
| 02/01/1995 | EP0519950B1 Pharmaceutical composition |
| 02/01/1995 | CN2188397Y Disposable ball pessary |
| 02/01/1995 | CN1098085A Chlorofluoroether compositions and preparation thereof |
| 02/01/1995 | CN1098009A Extrudable composition for topical or transdermal drug delivery |
| 02/01/1995 | CN1098004A Bone strengthening injection |
| 02/01/1995 | CN1097987A Transdermal hormone replacement therapy |
| 02/01/1995 | CN1097985A Soft viaminate capsule and producing process thereof |
| 02/01/1995 | CN1097984A Methods for administering biological agents and microparticle compositions useful in these and other methods |
| 02/01/1995 | CN1097983A Concentrated Chinese medicine powder preparation and application technique |
| 02/01/1995 | CN1097982A Topical composition for inhibiting hair growth |
| 02/01/1995 | CN1097981A Bag for strengening brain and benefiting vitality |
| 02/01/1995 | CN1097980A 壳聚糖明胶海绵 Chitosan gelatin sponge |
| 01/31/1995 | US5385923 Treatment of degenerative diseases |
| 01/31/1995 | US5385907 Ointments containing FK-506 or derivatives thereof |
| 01/31/1995 | US5385890 Improved solubility; mixture with polyoxyethylene glycol sorbital alkyl ester |
| 01/31/1995 | US5385749 Directly compressible pulverulent composition and a process for obtaining the same |
| 01/31/1995 | US5385739 Stable compositions of gastroprotected omerprazole microgranules and process for the production thereof |
| 01/31/1995 | US5385738 Sustained-release injection |
| 01/31/1995 | US5385737 Surfactant-containing seamless capsules |
| 01/31/1995 | US5385736 Sheet with coating of melatonin, carbitol and pressure sensitive adhesive containing terpolymers of acrylic esters, (substituted)acrylamides or N-vinylpyrrolidone/2-/, with vinyl acetate |
| 01/31/1995 | US5385734 Horseradish preparation for the treatment of nasal and sinus dysfunction |
| 01/31/1995 | CA1334165C Affinity associated vaccine |
| 01/29/1995 | CA2128954A1 Spermicidal anti-viral lubricant composition and method of using same |
| 01/28/1995 | CA2128821A1 Freeze-dried pharmaceutical dosage form and process for separation thereof |
| 01/28/1995 | CA2128820A1 Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof |
| 01/27/1995 | CA2128742A1 Oil-based and water-based adjuvant mixture |
| 01/26/1995 | WO1995002698A1 Composition and methods for transfecting eukaryotic cells |
| 01/26/1995 | WO1995002651A1 Seals for use in an aerosol delivery device |
| 01/26/1995 | WO1995002648A1 PRESSURE SENSITIVE ADHESIVE COMPOSITION WHICH IS WATER DISPERSIBLE UNDER ALKALINE pH CONDITIONS |
| 01/26/1995 | WO1995002628A1 Polyphosphazenes useful as immunoadjuvants |
| 01/26/1995 | WO1995002416A1 Hydrogel microencapsulated vaccines |
| 01/26/1995 | WO1995002415A1 Phosphazene polyelectrolytes as immunoadjuvants |
| 01/26/1995 | WO1995002404A1 Transdermal melatonin delivery system |
| 01/26/1995 | WO1995002401A1 Plaster |
| 01/26/1995 | WO1995002398A1 Pharmaceutical composition for immunomodulating and adjuvant treatment |
| 01/26/1995 | WO1995002397A1 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 01/26/1995 | WO1995002396A1 Matrix-entrapped beadlet preparation |
| 01/26/1995 | WO1995002395A1 Encapsulated dosage forms |
| 01/26/1995 | WO1995002394A1 Co-micronized bicarbonate salt compositions |
| 01/26/1995 | WO1995002339A1 Shellac dispersions and coatings, and method of making |
| 01/26/1995 | WO1994027589A3 Antidepressant dosage form |
| 01/26/1995 | CA2167081A1 Hydrogel microencapsulated vaccines |
| 01/26/1995 | CA2167050A1 Matrix-entrapped beadlet preparation |
| 01/26/1995 | CA2166534A1 Pressure sensitive adhesive composition which is water dispersible under alkaline ph conditions |
| 01/25/1995 | EP0635531A2 Liquid copolymers of epsilon-caprolactone and lactide |
| 01/25/1995 | EP0635272A1 Liquid absorbable copolymers for parenteral applications |
| 01/25/1995 | EP0635265A1 Controlled release pharmaceutical compositions based on one or more pharmaceutically acceptable salts of gamma hydroxy-butyric acid |
| 01/25/1995 | EP0635262A2 Package structure of drug-containing pressure-sensitive adhesive sheet |